{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T11:37:14Z","timestamp":1792496234333,"version":"4.5.0"},"reference-count":40,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T00:00:00Z","timestamp":1472428800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Obesity"],"published-print":{"date-parts":[[2016,9]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To characterize the adoption of antiobesity pharmacotherapies, as compared with that of the newest antidiabetes pharmacotherapy, subtype 2 sodium\u2010glucose transport protein inhibitors (SGLT2s), among prescribers in the United States.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A retrospective analysis of 2012 to 2015 data extracted from the IMS Health National Prescription Audit\u2122 and Xponent\u2122 assessed adoption rates of antiobesity pharmacotherapies and SGLT2s.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The number of dispensed antidiabetes prescriptions was 15 times the number of dispensed antiobesity prescriptions. The antiobesity market share was: 74.0% phentermine, 18.6% new antiobesity pharmacotherapies. The mean increase in prescriptions\/month were: 25,259 for SGLT2s, 5,154 for new antiobesity pharmacotherapies, and 2,718 for phentermine. Medical specialties prescribing the majority of the analysis medications were Family Medicine\/General Practice and Internal Medicine. Endocrinology had the highest prevalence of prescribers of any subspecialty.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>The adoption rate of SGLT2s was nearly exponential, while the adoption rate of new antiobesity pharmacotherapies was linear. Considering the relative prevalence of obesity to diabetes and that obesity is a major cause of diabetes, these results are paradoxical and suggest systematic barriers against the prescribing of antiobesity pharmacotherapies. The under\u2010prescribing of antiobesity pharmacotherapies is widely acknowledged, but this is the first prescription data of these new medications to demonstrate its extent in the United States.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/oby.21533","type":"journal-article","created":{"date-parts":[[2016,8,29]],"date-time":"2016-08-29T01:16:10Z","timestamp":1472433370000},"page":"1955-1961","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":117,"title":["Low adoption of weight loss medications: A comparison of prescribing patterns of antiobesity pharmacotherapies and\n                    <scp>SGLT<\/scp>\n                    2s"],"prefix":"10.1002","volume":"24","author":[{"given":"Catherine E.","family":"Thomas","sequence":"first","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes &amp; Metabolism, Comprehensive Weight Control Center Weill Cornell Medical College New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth A.","family":"Mauer","sequence":"additional","affiliation":[{"name":"Department of Healthcare Policy &amp; Research, Division of Biostatistics &amp; Epidemiology Weill Cornell Medical College New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpana P.","family":"Shukla","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes &amp; Metabolism, Comprehensive Weight Control Center Weill Cornell Medical College New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samrat","family":"Rathi","sequence":"additional","affiliation":[{"name":"VIVUS, Inc., Mountain View California USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis J.","family":"Aronne","sequence":"additional","affiliation":[{"name":"Department of Medicine, Division of Endocrinology, Diabetes &amp; Metabolism, Comprehensive Weight Control Center Weill Cornell Medical College New York New York USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2016,8,29]]},"reference":[{"key":"e_1_2_7_2_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2014.732"},{"key":"e_1_2_7_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(05)66378-7"},{"key":"e_1_2_7_4_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.annepidem.2012.01.001"},{"key":"e_1_2_7_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.21136"},{"key":"e_1_2_7_6_1","unstructured":"National Center for Health Statistics.Health United States 2014. Hyattsville MD: U.S. Department of Health and Human Services;2015. pp. 165."},{"key":"e_1_2_7_7_1","unstructured":"Centers for Disease Control and Prevention.National Diabetes Statistics Report: Estimates of Diabetes and its Burden in the United States 2014. Atlanta GA: U.S. Department of Health and Human Services;2014. pp. 5."},{"key":"e_1_2_7_8_1","doi-asserted-by":"publisher","DOI":"10.1037\/10510-004"},{"key":"e_1_2_7_9_1","unstructured":"World Health Organization.Obesity: Preventing and Managing the Global Epidemic \u2010 Report of a WHO Consultation on Obesity. Geneva: WHO;1997."},{"key":"e_1_2_7_10_1","unstructured":"National Institutes of Health.Clinical Guidelines on the Identification Evaluation and Treatment of Overweight and Obesity in Adults\u2013The Evidence Report. NIH Publication 98\u20104083;1998."},{"key":"e_1_2_7_11_1","unstructured":"National Institutes of Health.The Practical Guide: Identification Evaluation and Treatment of Overweight and Obesity in Adults. NIH Publication 00\u20104084; 2000."},{"key":"e_1_2_7_12_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-142-7-200504050-00011"},{"key":"e_1_2_7_13_1","doi-asserted-by":"publisher","DOI":"10.4158\/EP13155.GL"},{"key":"e_1_2_7_14_1","volume-title":"Recognition of Obesity as a Disease","author":"American Medical Association","year":"2013"},{"key":"e_1_2_7_15_1","first-page":"S1","article-title":"Guidelines (2013) for managing overweight and obesity in adults","volume":"22","author":"Jensen MD","year":"2014","journal-title":"Obesity"},{"key":"e_1_2_7_16_1","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2014-3415"},{"key":"e_1_2_7_17_1","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4158\/endp.19.2.a38267720403k242","article-title":"AACE comprehensive diabetes management algorithm","volume":"19","author":"American Association of Clinical Endocrinologists.","year":"2013","journal-title":"Endocr Pract"},{"key":"e_1_2_7_18_1","volume-title":"HSRN Data Brief: National Prescription Audit","author":"IMS Institute for Healthcare Informatics","year":"2011"},{"key":"e_1_2_7_19_1","volume-title":"2014 Physician Specialty Data Book","author":"Association of American Medical Colleges Center for Workforce Studies","year":"2014"},{"key":"e_1_2_7_20_1","volume-title":"2013 State Physician Workforce Data Book","author":"Association of American Medical Colleges Center for Workforce Studies","year":"2013"},{"key":"e_1_2_7_21_1","unstructured":"United States Census Bureau. Census regions and divisions of the United States [on the Internet].http:\/\/www2.census.gov\/geo\/pdfs\/maps-data\/maps\/reference\/us_regdiv.pdf. Updated July 28 2015. Accessed February 16 2016."},{"key":"e_1_2_7_22_1","unstructured":"National Center for Chronic Disease Prevention and Health Promotion. Obesity prevalence maps [Web page]. Centers for Disease Control and Prevention website.www.cdc.gov\/obesity\/data\/prevalence-maps.html. Updated September 11 2015. Accessed October 20 2015."},{"key":"e_1_2_7_23_1","unstructured":"Division of Diabetes Translation. Maps of trends in diagnosed diabetes. April 2016 [on the Internet]. Centers for Disease Control and Prevention website.www.cdc.gov\/diabetes\/statistics\/slides\/maps_diabetes_trends.pdf. Updated January 2015. Access October 20 2015."},{"key":"e_1_2_7_24_1","doi-asserted-by":"publisher","DOI":"10.1001\/archinternmed.2009.479"},{"key":"e_1_2_7_25_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20584"},{"key":"e_1_2_7_26_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)60205-5"},{"key":"e_1_2_7_27_1","doi-asserted-by":"publisher","DOI":"10.3810\/pgm.2014.10.2817"},{"key":"e_1_2_7_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20309"},{"key":"e_1_2_7_29_1","doi-asserted-by":"publisher","DOI":"10.1111\/dom.12054"},{"key":"e_1_2_7_30_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-0612"},{"key":"e_1_2_7_31_1","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(13)70084-6"},{"key":"e_1_2_7_32_1","unstructured":"Farxiga for US Healthcare Professionals. Formulary finder [Web page]. AstraZeneca website.https:\/\/www.farxiga\u2010hcp.com\/access\u2010savings\/formulary\u2010finder.html. Accessed February 15 2016."},{"key":"e_1_2_7_33_1","unstructured":"Invokana for US Healthcare Professionals. Patient affordability and access map [Web page]. Janssen website.http:\/\/www.invokanahcp.com\/formulary\u2010map#. Updated February 08 2016. Accessed February 15 2016."},{"key":"e_1_2_7_34_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.cmet.2016.02.005"},{"key":"e_1_2_7_35_1","doi-asserted-by":"publisher","DOI":"10.2337\/dc10-2415"},{"key":"e_1_2_7_36_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2012.66"},{"key":"e_1_2_7_37_1","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.111.024927"},{"key":"e_1_2_7_38_1","doi-asserted-by":"publisher","DOI":"10.1002\/oby.20596"},{"key":"e_1_2_7_39_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1504720"},{"key":"e_1_2_7_40_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amepre.2012.01.005"},{"key":"e_1_2_7_41_1","doi-asserted-by":"publisher","DOI":"10.1038\/oby.2009.69"}],"container-title":["Obesity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Foby.21533","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Foby.21533","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/oby.21533","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,17]],"date-time":"2023-09-17T13:32:55Z","timestamp":1694957575000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/oby.21533"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,8,29]]},"references-count":40,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["10.1002\/oby.21533"],"URL":"https:\/\/doi.org\/10.1002\/oby.21533","archive":["Portico"],"relation":{},"ISSN":["1930-7381","1930-739X"],"issn-type":[{"value":"1930-7381","type":"print"},{"value":"1930-739X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,8,29]]},"assertion":[{"value":"2016-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-04-02","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2016-08-29","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}